Type a term, then click a field below.

Search | advanced search

keepers


Type a term, then click a field below.

Search | simple search





0 subtopics

 

Bone Marrow PurgingFollow by RSS 

You've reached a pubget topic page. Below are the latest papers on this topic, with subtopics on the left.

keywords > Therapeutics > Blood Component Removal > Bone Marrow Purging

Latest papers

[Allogeneic stem cell transplantation in the management of acute myeloid leukemia].

The continuing contribution of gene marking to cell and gene therapy.

Oncolytic Coxsackievirus A21 as a novel therapy for multiple myeloma.

The role of rituximab in autologous and allogeneic hematopoietic stem cell transplantation for non-Hodgkin's lymphoma.

Is intensive insulin therapy safe in the critically ill?

Peripheral blood stem cell tumor cell contamination and survival of neuroblastoma patients.

The evolving role of autologous and allogeneic stem cell transplantation in follicular lymphoma.

Successful treatment of a patient with POEMS syndrome by tandem high-dose chemotherapy with autologous CD34+ purged stem cell rescue.

Factors affecting volume reduction and red blood cell depletion of bone marrow on the COBE Spectra cell separator before haematopoietic stem cell transplantation.

Autologous stem cell transplant in ALL: who should we be transplanting in first remission?

Effect of body mass index on mortality of patients with lymphoma undergoing autologous hematopoietic cell transplantation.

[The impact of stem cell therapy in hematology and oncology].

Monoclonal antibody therapy for B-cell malignancies.

A novel triple purge strategy for eliminating chronic myelogenous leukemia (CML) cells from autografts.

Ex vivo expansion of mafosfamide-purged PBPC products.

Treatment of refractory CMV-infection following hematopoietic stem cell transplantation with the combination of foscarnet and leflunomide.

In-vivo purging with the anti-CD20 antibody rituximab along with standard allogeneic peripheral blood stem cell transplantation (PBSCT) for relapsed childhood pre-B acute lymphoblastic leukaemia (ALL).

Purging of murine erythroblastic leukemia by ZnPcS2P2-based-photodynamic therapy.

Randomised comparison of two B-cell purging protocols for patients with B-cell non-Hodgkin lymphoma: in vivo purging with rituximab versus ex vivo purging with CliniMACS CD34 cell enrichment device.

[Allogenic stem cell transplantation--a case example: prospect for a new life].

page 1 2 3 4 5 6 7 8 9 10 11 ...